Study In Asthma Control

• Status: Terminated
• Trial end date: 2006-03-28
• Target enrollment: 0
• Participant gender: All

Summary

This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fluticasone; Salmeterol Xinafoate; Xhance

Criteria

Inclusion Criteria:

• documented clinical history of asthma and receiving regular maintenance therapy.

Exclusion Criteria:

• Using oral/parenteral or depot corticosteroids within 12 weeks of visit 1.

• History of heavy smoking or substance abuse.

• Females who are pregnant or lactating.

• Required emergency room treatment for their asthma 12 weeks prior to Visit 1.

• Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician.

• Other medical criteria will be evaluated at the screening visit.